Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2020, Vol. 47 Issue (3): 409-411    DOI: 10.31083/j.ceog.2020.03.5068
Case Report Previous articles | Next articles
A rare BMP15 genetic variant in a patient with premature ovarian insufficiency and two spontaneous pregnancies
R. Robeva1, *(), S. Andonova2, M. Glushkova3, T. Todorov4, A. Elenkova1, A. Savov2, S. Zacharieva1, A. Todorova3, 4
1Department of Endocrinology, Medical Faculty, Medical University-Sofia, Sofia, Bulgaria
2National Genetic Laboratory, University Hospital of Obstetrics and Gynecology "Maichin dom", Medical Faculty, Medical University-Sofia, Sofia, Bulgaria
3Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University-Sofia, Sofia, Bulgaria
4Genetic Medico-Diagnostic Laboratory "Genica", Sofia, Bulgaria
Download:  PDF(447KB)  ( 254 ) Full text   ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Introduction: Premature ovarian insufficiency (POI) is characterized by an unusually early depletion of the ovarian follicular pool in women. Genetic progress in recent years has allowed the identification of different genes that can predispose to the development of POI. Bone morphogenetic protein 15 (BMP15) genetic variants have been associated with diminished ovarian reserve and subfertility in animals and humans. Materials and Methods: Herein, the authors present a 34-year-old Caucasian woman with normal pubertal development, one uncomplicated pregnancy and two spontaneous pregnancies after POI diagnosis. Results: A very rare variant c.269T>C (p.Ile90Thr) in exon 1 of the BMP15 gene was detected. Conclusions: The proper differentiation between genetic variants associated with premature ovarian ageing and mutations that can attribute to irreversible early gonadal impairments is an important task of future studies.

Key words:  Premature ovarian insufficiency      Fertility      BMP15 genetic variants     
Submitted:  10 November 2018      Accepted:  24 January 2019      Published:  15 June 2020     
Fund: 
Grant 2016, Project 360/2016; Contract 92/2016/Medical University Sofia
*Corresponding Author(s):  RALITSA ROBEVA     E-mail:  rali_robeva@yahoo.com

Cite this article: 

R. Robeva, S. Andonova, M. Glushkova, T. Todorov, A. Elenkova, A. Savov, S. Zacharieva, A. Todorova. A rare BMP15 genetic variant in a patient with premature ovarian insufficiency and two spontaneous pregnancies. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 409-411.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2020.03.5068     OR     https://ceog.imrpress.com/EN/Y2020/V47/I3/409

Figure 1.  BMP15 p.Ile90Thr variant: A) BMP15 gene location. B) BMP15 p.Ile90Thr variant location. C) Clinical characteristics of the BMP15 p.Ile90Thr variant.

[1] European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber L., Davies M., Anderson R., Bartlett J., Braat D., Cartwright B., et al.: “ESHRE Guideline: management of women with premature ovarian insufficiency”. Hum. Reprod., 2016, 31, 926.
doi: 10.1093/humrep/dew027 pmid: 27008889
[2] Bachelot A., Nicolas C., Bidet M., Dulon J., Leban M., Golmard J.L., et al.: “Long-term outcome of ovarian function in women with intermittent premature ovarian insufficiency”. Clin. Endocrinol. (Oxf.), 2017, 86, 223.
doi: 10.1111/cen.2017.86.issue-2
[3] Bidet M., Bachelot A., Bissauge E., Golmard J.L., Gricourt S., Dulon J., et al.: “Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure”. J. Clin. Endocrinol. Metab., 2011, 96, 3864.
doi: 10.1210/jc.2011-1038 pmid: 21994953
[4] Persani L., Rossetti R., Di Pasquale E., Cacciatore C., Fabre S.: “The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders”. Hum. Reprod. Update., 2014, 20, 869.
doi: 10.1093/humupd/dmu036
[5] Di Pasquale E., Beck-Peccoz P., Persani L.: “Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene”. Am. J. Hum. Genet., 2004, 75, 106.
doi: 10.1086/422103
[6] Di Pasquale E., Rossetti R., Marozzi A., Bodega B., Borgato S., Cavallo L., et al.: “Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure”. J. Clin. Endocrinol. Metab., 2006, 91, 1976.
doi: 10.1210/jc.2005-2650 pmid: 16464940
[7] Rossetti R., Di Pasquale E., Marozzi A., Bione S., Toniolo D., Grammatico P., et al.: “BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein”. Hum. Mutat., 2009, 30, 804.
doi: 10.1002/humu.20961 pmid: 19263482
[8] Laissue P., Christin-Maitre S., Touraine P., Kuttenn F., Ritvos O., Aittomaki K., et al.: “Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure”. Eur. J. Endocrinol., 2006, 154, 739.
doi: 10.1530/eje.1.02135 pmid: 16645022
[9] Tiotiu D., Alvaro Mercadal B., Imbert R., Verbist J., Demeestere I., De Leener A., et al.: “Variants of the BMP15 gene in a cohort of patients with premature ovarian failure”. Hum. Reprod., 2010, 25, 1581.
doi: 10.1093/humrep/deq073 pmid: 20364024
[10] Ledig S., Röpke A., Haeusler G., Hinney B., Wieacker P.: “BMP15 mutations in XX gonadal dysgenesis and premature ovarian failure”. Am. J. Obstet. Gynecol., 2008, 198, e1.
[1] Pelin Kutlu, Seda Karabulut, Oya Korkmaz. Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1025-1031.
[2] Arzu Yurci, Nur Dokuzeylul Gungor, Tugba Gurbuz. Defective expression of endometrial BMP-2 contributes to subfertility in women with unexplained infertility[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1094-1098.
[3] Ranit Hizkiyahu, Shannon Salvador, Michael H. Dahan. Ovarian stimulation for fertility preservation in a woman with borderline serous ovarian tumor causing a large fluctuating subcutaneous fluid collection: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1215-1218.
[4] Lorenz Hinterleitner, Herbert Kiss, Johannes Ott. The impact of Cesarean section on female fertility: a narrative review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 781-786.
[5] Sema Karakaş, Cihan Kaya, Sebastian Daniel Schäfer, Mislav Mikuš, Milan Terzic, Bekhzod Abdullaev, Alessandra Andrisani. Fertility-sparing in cancer patients[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 787-794.
[6] Martin Klein, Lenka Lapides, Denisa Fecmanová, Ivan Varga. Novel cellular entities and their role in the etiopathogenesis of female idiopathic infertility—a review article[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 461-465.
[7] Banuhan Şahin, Buğra Şahin, Pervin Karlı, Görker Sel, Şafak Hatırnaz, Osman Fadıl Kara, Andrea Tinelli. Level of depression and hopelessness among women with infertility during the outbreak of COVID-19: a cross-sectional investigation[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 594-600.
[8] R. Duraker, E.S. Guvendag Guven, S. Dilbaz, A. Mentese, S. Aydın, S. Guven. Oxidative stress status in severe OHSS patients who underwent long agonist protocol intracytoplasmic sperm injection cycles[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 312-316.
[9] Elisa Zambrotta, Luisa Maria Di Gregorio, Federica Di Guardo, Roberta Agliozzo, Giuliana Chiara Maugeri, Ferdinando Antonio Gulino, Silvia Cutello, Maria Cecilia Cerana, Marco Palumbo. Congenital uterine anomalies and perinatal outcomes: a retrospective single-center cohort study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 160-163.
[10] Masataka Ono, Junya Kojima, Ei Hasegawa, Yotaro Takaesu, Toru Sasaki, Hirotaka Nishi. Anti-Müllerian hormone levels following laparoscopic ovarian cystectomy with subcutaneous abdominal wall lifting for ovarian endometriomas[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 91-97.
[11] A. Yaylalı, M. Bakacak, Z. Bakacak, F. Tolun. An investigation of the effects on follicular-embryonal development and pregnancy outcomes of serum and follicular fluid ischemia-modified albumin in cases of unexplained infertility receiving in vitro fertilization treatment[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 835-839.
[12] I. Thanaboonyawat, P. Chera-aree, S. Petyim, R. Choavaratana, P. Laokirkkiat. The effect of three-month topical testosterone gel application on semen quality in men with oligozoospermia and low serum testosterone levels[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 875-881.
[13] K. Okuno, K. Kitaya, N. Kim, K. Yamaguchi, H. Matsubayashi, T. Ishikawa. Case report of successful live birth in an infertile couple with male idiopathic hypogonadotropic hypogonadism/azoospermia and atypical polypoid adenomyoma of the uterus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 972-973.
[14] B.G. Kadioglu, B. Gundogdu, N. Kurt, A. Ozbek Bilgin, H. Suleyman, Z. Suleyman. The effect of rhodiola rosea root extract on stress-induced ovarian damage, infertility and reproductive disorders in female rats[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 530-536.
[15] L. Mamas, E. Mamas. Prophylactic cervical cerclage, fully embedded, for twin pregnancies following fertility treatment[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 238-242.
No Suggested Reading articles found!